Prestige Consumer Healthcare (PBH) Common Equity (2011 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Common Equity of $1.8 billion for Q4 2025, up 2.29% year-over-year from $1.8 billion in Q4 2024, and little changed quarter-over-quarter from $1.8 billion in Q3 2025.
Prestige Consumer Healthcare (PBH) Common Equity (2011 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Common Equity history runs 15 years deep, the most recent figure standing at $1.8 billion for Q4 2025.
- In Q4 2025, Common Equity rose 2.29% year-over-year to $1.8 billion; the TTM figure through Dec 2025 stood at $1.8 billion (up 2.29% YoY), while the FY2025 annual figure was $1.8 billion, up 10.86% from the prior year.
- Common Equity for Q4 2025 stood at $1.8 billion, roughly flat from $1.8 billion in the prior quarter.
- The five-year high for Common Equity was $1.9 billion in Q2 2025, with the low at $1.4 billion in Q1 2021.
- The 5-year median for Common Equity is $1.6 billion (2022), against an average of $1.6 billion.
- The sharpest annual moves came in 2022 and 2023: Common Equity increased 16.15% in 2022, then retreated 8.27% in 2023.
- Prestige Consumer Healthcare's Common Equity stood at $1.5 billion in 2021, then increased by 11.1% to $1.7 billion in 2022, then slipped by 5.12% to $1.6 billion in 2023, then grew by 11.74% to $1.8 billion in 2024, then rose by 2.29% to $1.8 billion in 2025.
- Business Quant data shows PBH's Common Equity at $1.8 billion in Q4 2025, $1.8 billion in Q3 2025, and $1.9 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 4.05 Bn |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - | 1.89 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.89 Bn |
| Dec 31, 2025 | 1.83 Bn |
| Sep 30, 2025 | 1.82 Bn |
| Jun 30, 2025 | 1.86 Bn |
| Mar 31, 2025 | 1.83 Bn |
| Dec 31, 2024 | 1.79 Bn |
| Sep 30, 2024 | 1.73 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | 1.66 Bn |
| Dec 31, 2023 | 1.60 Bn |
| Sep 30, 2023 | 1.54 Bn |
| Jun 30, 2023 | 1.48 Bn |
| Mar 31, 2023 | 1.45 Bn |
| Dec 31, 2022 | 1.69 Bn |
| Sep 30, 2022 | 1.62 Bn |
| Jun 30, 2022 | 1.58 Bn |
| Mar 31, 2022 | 1.58 Bn |
| Dec 31, 2021 | 1.52 Bn |
| Sep 30, 2021 | 1.46 Bn |
| Jun 30, 2021 | 1.42 Bn |